Assessment of Lipiodol Deposition and Residual Cancer for Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization via Iodine-Based Material Decomposition Images with Spectral Computed Tomography Imaging: A Preliminary Study
Authors:
Open Access
- 5 August 2015
- journal article
- Published by Brieflands in Iranian Journal of Radiology
- Vol. 12 (4) , e26009
Abstract
Background: It is critical to follow up hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) in clinical practice. Computed tomography (CT) is used to assess lipiodol deposition, whereas it is difficult to assess hypovascular residual cancer masked by lipiodol. In contrast, magnetic resonance imaging (MRI) is superior to CT in showing residual cancer, but cannot display lipiodol deposition. Objectives: The aim of this study was to investigate the value of spectral CT imaging in both lipiodol deposition and residual cancer for HCC patients after TACE. Patients and Methods: Ten HCC patients after treated with TACE underwent Discovery CT750 HD and MRI750 3T examination. Receiver operating characteristic (ROC) curves of iodine-based material decomposition images, monochromatic images and conventional CT images were generated. Results: Consequently, 30 residual lesions were detected in MRI of 10 patients. They were found in iodine-based images and monochromatic images versus 29 in conventional CT images. The area under ROC curves for the lesion-to-normal parenchyma ratio (LNR) on arterial phase (AP) in iodine-based material decomposition images, monochromatic images and conventional CT images were 0.933, 0.833 and 0.817, respectively. Conclusion: The study data highlighted good value of iodine-based material decomposition images of spectral CT in assessment of both lipiodol deposition and residual cancer for follow-up of HCC patients previously treated with TACE. Keywords: Tomography; Magnetic Resonance Imaging; Carcinoma; HepatocellularKeywords
This publication has 24 references indexed in Scilit:
- Safety and Efficacy of Transcatheter Arterial Chemoemboliazation in the Real-Life Management of Unresectable Hepatocellular CarcinomaHepatitis Monthly, 2013
- Different Faces of Hepatocellular Carcinoma as a Health Threat in 21st CenturyHepatitis Monthly, 2013
- Imaging and Imaging-Guided Interventions in the Diagnosis and Management of Hepatocellular Carcinoma (HCC)-Review of EvidenceIranian Journal of Radiology, 2012
- Dual energy spectral CT imaging of insulinoma—Value in preoperative diagnosis compared with conventional multi-detector CTEuropean Journal of Radiology, 2012
- Epidemiology and Surveillance of Hepatocellular CarcinomaLiver Cancer, 2012
- Hepatocellular CarcinomaNew England Journal of Medicine, 2011
- Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinomaOncology Reports, 2010
- Hepatocellular Carcinoma: Epidemiology, Surveillance, and DiagnosisSeminars in Liver Disease, 2010
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Hepatocellular carcinoma: surgical indications and resultsCritical Reviews in Oncology/Hematology, 2003